A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease.
Werner MH, Olanow CW, McGarry A, Meyer C, Kruger S, Klint C, Pellecchia J, Walaker S, Ereshefsky L, Blob L, Hassman H, Rodriguez C, Samara E, Safirstein B, Ellenbogen A.
Werner MH, et al.
J Parkinsons Dis. 2024;14(2):325-334. doi: 10.3233/JPD-230319.
J Parkinsons Dis. 2024.
PMID: 38251063
Free PMC article.
Clinical Trial.